284 related articles for article (PubMed ID: 32370568)
1. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease.
Hadley T; Gillespie S; Espinoza H; Prince J; Gronbaek H; Chandrakasan S; Kuguthasan S; Kolachala VL; Gupta NA
Autoimmunity; 2020 Aug; 53(5):253-260. PubMed ID: 32370568
[No Abstract] [Full Text] [Related]
2. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
3. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.
Aarslev K; Dige A; Greisen SR; Kreutzfeldt M; Jessen N; Vilstrup H; Deleuran B; Grønbæk H
Scand J Gastroenterol; 2017 Jan; 52(1):93-99. PubMed ID: 27604386
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents.
Rojas CP; Bodicharla R; Campuzano-Zuluaga G; Hernandez L; Rodriguez MM
Fetal Pediatr Pathol; 2014 Aug; 33(4):202-9. PubMed ID: 24754367
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children.
Behairy OG; Behiry EG; El Defrawy MS; El Adly AN
Scand J Clin Lab Invest; 2020 Feb; 80(1):59-65. PubMed ID: 31762332
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
Saich R; Chapman R
World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656
[TBL] [Abstract][Full Text] [Related]
8. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
Singh H; Balouch F; Noble C; Lewindon P
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents.
Ferri PM; Simões E Silva AC; Torres KCL; Silva SLC; Aquino DJQ; Ferreira MLM; Fagundes EDT; Miranda DM; Ferreira AR
J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):204-211. PubMed ID: 29045346
[TBL] [Abstract][Full Text] [Related]
10. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis.
Crescente JG; Dellavance A; Diniz MA; Carrilho FJ; Andrade LEC; Cançado ELR
Clinics (Sao Paulo); 2021; 76():e2228. PubMed ID: 33567045
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL
Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586
[TBL] [Abstract][Full Text] [Related]
15. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
[TBL] [Abstract][Full Text] [Related]
16. Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders.
Preuss B; Berg C; Dengjel J; Stevanovic S; Klein R
Liver Int; 2012 Feb; 32(2):249-57. PubMed ID: 22098431
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
18. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
19. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system.
Kaya M; Angulo P; Lindor KD
J Hepatol; 2000 Oct; 33(4):537-42. PubMed ID: 11059857
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
Rocha HC; Vilela EG
Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
